Literature DB >> 20007830

Cone versus rod disease in a mutant Rpgr mouse caused by different genetic backgrounds.

Sandra Brunner1, Sergej Skosyrski, Renate Kirschner-Schwabe, Klaus-Peter Knobeloch, John Neidhardt, Silke Feil, Esther Glaus, Ulrich F O Luhmann, Klaus Rüther, Wolfgang Berger.   

Abstract

PURPOSE: To establish mouse models for RPGR-associated diseases by generating and characterizing an Rpgr mutation (in-frame deletion of exon 4) in two different genetic backgrounds (BL/6 and BALB/c).
METHODS: Gene targeting in embryonic stem (ES) cells was performed to introduce a in-frame deletion of exon 4 in the Rpgr gene (Rpgr(DeltaEx4)). Subsequently, the mutation was introduced in two different inbred mouse strains by successive breeding. Mutant and wild-type mice of both strains were characterized by electroretinography (ERG) and histology at five time points (1, 3, 6, 9, and 12 months). RPGR transcript amounts were assessed by quantitative RT-PCR. A variety of photoreceptor proteins, including RPGR-ORF15, RPGRIP, PDE6delta/PrBPdelta, rhodopsin, and cone opsin, were localized on retinal sections by immunohistochemistry.
RESULTS: Mislocalization of rhodopsin and cone opsin was an early pathologic event in mutant mice of both lines. In contrast, RPGR-ORF15 as well as RPGRIP1 and PDE6delta/PrBPdelta showed similar localizations in mutant and wild-type animals. Functional and histologic studies revealed a mild rod-dominated phenotype in mutant male mice on the BL/6 background, whereas a cone-dominated phenotype was observed for the same mutation in the BALB/c background.
CONCLUSIONS: Both Rpgr mutant mouse lines developed retinal disease with a striking effect of the genetic background. Cone-specific modifiers might influence the retinal phenotype in the BALB/c strain. The two lines provide models to study RPGR function in rods and cones, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007830     DOI: 10.1167/iovs.08-2742

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

1.  A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration.

Authors:  Zhijian Wu; Suja Hiriyanna; Haohua Qian; Suddhasil Mookherjee; Maria M Campos; Chun Gao; Robert Fariss; Paul A Sieving; Tiansen Li; Peter Colosi; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2015-04-15       Impact factor: 6.150

2.  Loss of human disease protein retinitis pigmentosa GTPase regulator (RPGR) differentially affects rod or cone-enriched retina.

Authors:  Kollu N Rao; Linjing Li; Wei Zhang; Richard S Brush; Raju V S Rajala; Hemant Khanna
Journal:  Hum Mol Genet       Date:  2016-01-24       Impact factor: 6.150

3.  Localizing the RPGR protein along the cilium: a new method to determine efficacies to treat RPGR mutations.

Authors:  R Da Costa; E Glaus; A Tiwari; B Kloeckener-Gruissem; W Berger; J Neidhardt
Journal:  Gene Ther       Date:  2015-01-29       Impact factor: 5.250

4.  RPGR-associated retinal degeneration in human X-linked RP and a murine model.

Authors:  Wei Chieh Huang; Alan F Wright; Alejandro J Roman; Artur V Cideciyan; Forbes D Manson; Dina Y Gewaily; Sharon B Schwartz; Sam Sadigh; Maria P Limberis; Peter Bell; James M Wilson; Anand Swaroop; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-15       Impact factor: 4.799

Review 5.  Gene augmentation for X-linked retinitis pigmentosa caused by mutations in RPGR.

Authors:  William A Beltran; Artur V Cideciyan; Alfred S Lewin; William W Hauswirth; Samuel G Jacobson; Gustavo D Aguirre
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-09       Impact factor: 6.915

6.  Stability and Safety of an AAV Vector for Treating RPGR-ORF15 X-Linked Retinitis Pigmentosa.

Authors:  Wen-Tao Deng; Frank M Dyka; Astra Dinculescu; Jie Li; Ping Zhu; Vince A Chiodo; Sanford L Boye; Thomas J Conlon; Kirsten Erger; Travis Cossette; William W Hauswirth
Journal:  Hum Gene Ther       Date:  2015-07-29       Impact factor: 5.695

7.  Cellular imaging demonstrates genetic mosaicism in heterozygous carriers of an X-linked ciliopathy gene.

Authors:  Sung Pyo Park; In Hwan Hong; Stephen H Tsang; Stanley Chang
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

8.  The interplay between RPGR, PDEδ and Arl2/3 regulate the ciliary targeting of farnesylated cargo.

Authors:  Denise Wätzlich; Ingrid Vetter; Katja Gotthardt; Mandy Miertzschke; Yong-Xiang Chen; Alfred Wittinghofer; Shehab Ismail
Journal:  EMBO Rep       Date:  2013-04-05       Impact factor: 8.807

9.  Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degeneration.

Authors:  Jason Charng; Artur V Cideciyan; Samuel G Jacobson; Alexander Sumaroka; Sharon B Schwartz; Malgorzata Swider; Alejandro J Roman; Rebecca Sheplock; Manisha Anand; Marc C Peden; Hemant Khanna; Elise Heon; Alan F Wright; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

10.  β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment.

Authors:  Jun Cai; Xiaoping Qi; Norbert Kociok; Sergej Skosyrski; Alonso Emilio; Qing Ruan; Song Han; Li Liu; Zhijuan Chen; Catherine Bowes Rickman; Todd Golde; Maria B Grant; Paul Saftig; Lutgarde Serneels; Bart de Strooper; Antonia M Joussen; Michael E Boulton
Journal:  EMBO Mol Med       Date:  2012-08-20       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.